Response to second-line therapy defines the potential for cure in patients with recurrent diffuse large B-cell lymphoma: Implications for the development of novel therapeutic strategies.
Clinical Lymphoma, Myeloma and Leukemia.
Times cited: 30
Targeted Treatment and New Agents in Diffuse Large B-Cell Lymphoma.
Seminars in Hematology.
Times cited: 21